AUGUSTA ANYAMA: Open Payments
NPI 1972126001 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 22 payments from 10 companies in 2025. Trend: 2023 $938 · 2024 $275 · 2025 $1,319
Food & beverage: $1,200Education: $119
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $449 |
| Teva Pharmaceuticals USA, Inc. | 3 | $249 |
| E.R. Squibb & Sons, L.L.C. | 3 | $150 |
| Supernus Pharmaceuticals, Inc. | 2 | $118 |
| Axsome Therapeutics, Inc. | 1 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $99 |
| Alkermes, Inc. | 1 | $86 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: INVEGA SUSTENNA, INVEGA, COBENFY, UZEDY, Qelbree, Auvelity, SPRAVATO, LYBALVI.
Industry payments across LA — which companies pay providers there.
